Aculys
Aculys Pharma, Inc.
Japan · $114.0M raised
- Business Model
- B2B
- Website
- aculys.com
- Total Funding
- $114.0M
- Last Round
- $30.0M Series CMar 2025
- Rounds
- 3
About
Clinical-stage biopharmaceutical company focused on neurology treatments in Japan, working to eliminate drug lag and drug loss.
Summary
Aculys is a Biotech company based in Japan. It has raised $114.0M in total across 3 rounds, most recently a $30.0M Series C round in Mar 2025. Investors include SoftBank, Catalys Pacific and HBM Healthcare Investments.
Tech & App Stack
3 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Mar 2025
Sign up to see all 3 rounds
Full funding history, per-round amounts, and investor participation.
Investors
.png)
Similar Companies
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract development and manufacturing organization (CDMO) focused exclusively on sterile ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company